Analysis of the key themes driving M&A activity reveals that artificial intelligence accounted for 7 medical devices deals announced in Q3 2022, worth a total value of $3.7m, according to GlobalData’s whitepaper on Artificial Intelligence in Medical Devices – M&A Deal Activity in Q3 2022. The $2.9m acquisition of Pilloxa by iZafe Group was the industry’s largest disclosed deal.
In value terms, artificial intelligence-related deal activity decreased by 82% in Q3 2022 compared with the previous quarter’s total of $20m and fell by 98% as compared to Q3 2021. Related deal volume increased by 133% in Q3 2022 versus the previous quarter and was 22% lower than in Q3 2021.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
| Target | Acquirer | Deal Value ($M) | Deal Date |
|---|---|---|---|
| Preventice | Boston Scientific | $1,225M | Jan-21 |
| Decipher Biosciences | Veracyte | $600M | Feb-21 |
| Modern Fertility | Roman Health Ventures | $225M | May-21 |
| Inventive Healthcare Solutions; Virusight Diagnostic | $111M | Aug-21 | |
| Vicarious Surgical | $102M | Apr-21 |
The top-ranked financial advisors supporting these M&A deals in 2022 were ARC Group; First Analysis Securities; Mangold Fondkommission with 1, 1, 1 deals respectively.
| Advisor Name | 2022 Rank | 2021 Rank |
|---|---|---|
| ARC Group | 1 | - |
| First Analysis Securities | 1 | - |
| Mangold Fondkommission | 1 | - |
| Turner Pope Investments (TPI) | 1 | - |
The top-ranked legal advisors supporting these M&A deals in 2022 were Bennett Jones; Bird & Bird; Nelson Mullins Riley & Scarborough with 1, 1, 1 deals respectively.
| Advisor Name | 2022 Rank | 2021 Rank |
|---|---|---|
| Bennett Jones | 1 | - |
| Bird & Bird | 1 | - |
| Nelson Mullins Riley & Scarborough | 1 | - |
| Rimon | 1 | - |
| Wilson Sonsini Goodrich & Rosati Professional | 1 | 1 |
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.
